Yahoo! News: Weight Loss News |
Orexigen obesity drug shows added benefits: studies (Reuters) Posted: 24 Oct 2009 10:01 AM PDT Reuters - Nearly half of patients who completed 56 weeks of treatment with Orexigen Therapeutics Inc's experimental obesity treatment, Contrave, lost at least 10 percent of their weight in a late-stage study and the drug also appeared to help cholesterol and blood sugar levels. |
You are subscribed to email updates from Yahoo! News: Weight Loss News To stop receiving these emails, you may unsubscribe now. | Email delivery powered by Google |
Google Inc., 20 West Kinzie, Chicago IL USA 60610 |
No comments:
Post a Comment